Nagarika Generics India Private Limited
Pharmaceutical company that manufactures and trades various healthcare products, medicines, and supplements.
2020 | Bangaluru, Karnataka (India) | Active
Nagarika Generics India Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.24 Cr
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Nagarika Generics India
Nagarika Generics India Private Limited (NGIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2020 (Four years and nine months 19 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Muralidhara Bindumalyam, Kishore Rajagopal, Anuradha Bindumalyam, and Four other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909KA2020PTC134808
- Company No.
134808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
Who are the key members and board of directors at Nagarika Generics India?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muralidhara Bindumalyam  | Director | 10-Jun-2020 | Current |
Kishore Rajagopal  | Additional Director | 19-Jun-2020 | Current |
| Anuradha Bindumalyam | Director | 10-Jun-2020 | Current |
| Muralidhara Ashwini | Director | 10-Jun-2020 | Current |
| Bindumalyam Muralidhar | Director | 10-Jun-2020 | Current |
| Muntimadagu Manjunatha | Director | 10-Jun-2020 | Current |
Financial Performance of Nagarika Generics India.
Nagarika Generics India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nagarika Generics India?
Unlock access to Nagarika Generics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kids Clinic India LimitedKishore Rajagopal is a mutual person
Acquity Labs Private LimitedKishore Rajagopal is a mutual person
- Trinity Medicity India Private Limited
Muralidhara Bindumalyam and Anuradha Bindumalyam are mutual person
- Bgs Renewable Energy And Infra Private Limited
Muralidhara Bindumalyam is a mutual person
- Shariff Nursing Home Private Limited
Muralidhara Bindumalyam and Anuradha Bindumalyam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nagarika Generics India?
Nagarika Generics India has a workforce of 3 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nagarika Generics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nagarika Generics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nagarika Generics India
Recent activity within the organization
- Annual General Meeting
Nagarika Generics India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Nagarika Generics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Director Appointment
Kishore Kumar Rajagopal was appointed as a Additional Director was appointed as a Additional Director on 19 Jun 2020 & has been associated with this company since 4 years 9 months .
- Director Appointment
Anil Laxmichand was appointed as a Additional Director was appointed as a Additional Director on 19 Jun 2020 & has been associated with this company since 4 years 9 months .
- Director Appointment
Muralidhara Gopalakrishnaiah Bindumalyam was appointed as a Director was appointed as a Director on 10 Jun 2020 & has been associated with this company since 4 years 9 months .
- Director Appointment
Anuradha Muralidhara Bindumalyam was appointed as a Director was appointed as a Director on 10 Jun 2020 & has been associated with this company since 4 years 9 months .
Frequently asked questions
What is the Incorporation or founding date of Nagarika Generics India Private Limited?
Nagarika Generics India Private Limited was incorporated on 10 Jun 2020.
What is authorized share capital and paid-up capital of Nagarika Generics India Private Limited?
The authorized share capital of Nagarika Generics India Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 2.24 Cr.
Who are the current board members & directors of Nagarika Generics India Private Limited?
Currently 7 directors are associated with Nagarika Generics India Private Limited.
- Muralidhara Gopalakrishnaiah Bindumalyam
- Kishore Kumar Rajagopal
- Anuradha Muralidhara Bindumalyam
- Muralidhara Bindumalyam Ashwini
- Bindumalyam Aishwarya Muralidhar
- Muntimadagu Rathnam Manjunatha
- Anil Laxmichand
What is the registered address of Nagarika Generics India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nagarika Generics India Private Limited is No.213 80 Feet Road 4Th Main Jp Nagar 2Nd Phase, India, Bangalore, Karnataka, 560078.
What is the corporate identification number (CIN) and company number of Nagarika Generics India Private Limited?
The corporate identification number (CIN) of Nagarika Generics India Private Limited is U51909KA2020PTC134808 and the company number is 134808 as per Ministry of Corporate Affairs (MCA).
How many employees does Nagarika Generics India Private Limited currently have?
As Per 2022 financial reports, 3 employees are currently employed by Nagarika Generics India Private Limited.
When was the last Balance Sheet of Nagarika Generics India Private Limited filed with the ROC?
The most recent Balance Sheet for Nagarika Generics India Private Limited was filed with the ROC on 31 Mar 2024.